Application of artificial neural networks in estimating predictive factors and therapeutic efficacy in idiopathic membranous nephropathy.
暂无分享,去创建一个
R. Naumovic | D. Furuncic | G Basta-Jovanovic | R Naumovic | D Furuncic | D Jovanovic | M Stosovic | V Lezaic | D. Jovanovic | G. Basta-Jovanovic | M. Stosovic | V. Lezaic
[1] D. C. Cattran,et al. Idiopathic membranous glomerulonephritis. , 2001, Kidney international.
[2] A. Lupo,et al. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. , 1998, Journal of the American Society of Nephrology : JASN.
[3] M. Leontsini,et al. Relationship between interstitial infiltrates and steroid responsiveness of proteinuria in membranous nephropathy. , 1994, Nephrology, Dialysis and Transplantation.
[4] G. Remuzzi,et al. Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[5] A. Magil,et al. Focal glomerulosclerosis in idiopathic membranous glomerulonephritis. , 1992, Kidney international.
[6] M. Raftery,et al. Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathy. , 1995, Kidney international.
[7] B. Marx,et al. Prediction in idiopathic membranous nephropathy. , 1999, Kidney international.
[8] J. Wetzels,et al. Prognostic factors in idiopathic membranous nephropathy. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] R. Falk,et al. A review of therapeutic studies of idiopathic membranous glomerulopathy. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] C. Cardella,et al. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. , 1989, The New England journal of medicine.
[11] E. Jones,et al. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] Tom Greene,et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[13] G. D'Amico,et al. Urinary excretion of IgG and alpha(1)-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[14] N. Yorioka,et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. , 2004, Kidney international.
[15] G. Schumm,et al. Long-term prognosis of focal sclerosing glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes. , 1990, Clinical nephrology.
[16] T. Greene,et al. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.
[17] R. Glassock. Diagnosis and natural course of membranous nephropathy. , 2003, Seminars in nephrology.
[18] T. Saruta,et al. Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy. , 1992, Clinical nephrology.
[19] F. Locatelli,et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. , 1995, Kidney international.
[20] C. Ponticelli,et al. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group. , 1992, The New England journal of medicine.
[21] Sunil V. Rao,et al. Management of glomerular proteinuria: a commentary. , 2003, Journal of the American Society of Nephrology : JASN.
[22] J. Velosa,et al. Idiopathic membranous nephropathy: the natural history of untreated patients. , 1988, Kidney international.
[23] Y. Pei,et al. Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. , 1992, Kidney international.
[24] M. Burnier,et al. Usefulness of artificial neural networks to predict follow-up dietary protein intake in hemodialysis patients. , 2004, Kidney international.
[25] M. Endoh,et al. Analysis of prognostic predictors in idiopathic membranous nephropathy. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[26] K. Simpson,et al. An artificial neural network can select patients at high risk of developing progressive IgA nephropathy more accurately than experienced nephrologists. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[27] D. Shoskes,et al. Prediction of early graft function in renal transplantation using a computer neural network. , 1998, Transplantation Proceedings.
[28] R. Glassock. The treatment of idiopathic membranous nephropathy: a dilemma or a conundrum? , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[29] N. Muirhead. Management of idiopathic membranous nephropathy: evidence-based recommendations. , 1999, Kidney international. Supplement.
[30] Drasko Furundzic,et al. Neural networks approach to early breast cancer detection , 1998, J. Syst. Archit..
[31] S. Takebayashi,et al. Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and in adult Japanese. , 1987, Clinical nephrology.
[32] J. Wetzels,et al. Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency. , 1998, QJM : monthly journal of the Association of Physicians.